The sensitivity of the QuantiFERON®-TB Gold Plus assay in Zambian adults with active tuberculosis

International Journal of Tuberculosis and Lung Disease

Volumn 21, Issue 6, 2017, Pages 690-696

  Telisinghe, L ^a   Amofa Sekyi, M ^b   Maluzi, K ^b   Kaluba Milimo, D ^b   Cheeba Lengwe, M ^b   Chiwele, K ^b   Kosloff, B ^b,c   Floyd, S ^c   Bailey, S L ^b,c   Ayles, H ^b,c  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b ZAMBART   (Zambia)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Interferon gamma release assays; Latent tuberculous infection; Validity

Indexed keywords

ADULT; ARTICLE; BODY MASS; CD4 LYMPHOCYTE COUNT; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LATENT TUBERCULOSIS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MYCOBACTERIUM TUBERCULOSIS TEST KIT; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SPUTUM SMEAR; TUBERCULIN TEST; TUBERCULOSIS RAPID TEST; VENOUS BLOOD; ZAMBIAN; COMPARATIVE STUDY; INTERFERON GAMMA RELEASE ASSAY; MICROBIOLOGY; PROCEDURES; SENSITIVITY AND SPECIFICITY; SPUTUM; STATISTICAL MODEL; ZAMBIA;

ADULT; FEMALE; HIV INFECTIONS; HUMANS; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; LOGISTIC MODELS; MALE; SENSITIVITY AND SPECIFICITY; SPUTUM; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY; ZAMBIA;

EID: 85018892519     PISSN: 10273719     EISSN: 18157920     Source Type: Journal    
DOI: 10.5588/ijtld.16.0764     Document Type: Article

References (27)

1. Sonnenberg P, Glynn J R, Fielding K, Murray J, Godfrey-Faussett P, Shearer S.How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners J Infect Dis 2005; 191: 150-158.
2. Corbett E L, Marston B, Churchyard G J, De Cock K M.Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment Lancet 2006; 367: 926-937.
3. Churchyard G J, Fielding K L, Lewis J J, et al A trial of mass isoniazid preventive therapy for tuberculosis control N Engl J Med 2014; 370: 301-310.
4. Getahun H, Granich R, Sculier D, et al Implementation of isoniazid preventive therapy for people living with HIV worldwide: barriers and solutions AIDS 2010; 24 (Suppl 5): S57-S65.
5. Rangaka M X, Cavalcante S C, Marais B J, et al Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection Lancet 2015; 386: 2344-2353.
6. Getahun H, Matteelli A, Chaisson R E, Raviglione M.Latent Mycobacterium tuberculosis infection N Engl J Med 2015; 372: 2127-2135.
7. Pai M, Denkinger CM, Kik S V, et al Gamma interferon release assays for detection of Mycobacterium tuberculosis infection Clin Microbiol Rev 2014; 27: 3-20.
8. Metcalfe J Z, Everett C K, Steingart K R, et al Interferongamma release assays for active pulmonary tuberculosis diagnosis in adults in low-And middle-income countries: systematic review and meta-Analysis J Infect Dis 2011; 204 (Suppl 4): S1120-S1129.
9. Santin M, Munoz L, Rigau D.Interferon-gamma release assays for the diagnosis of tuberculosis and tuberculosis infection in HIV-infected adults: a systematic review and meta-Analysis PLOS ONE 2012; 7: e32482.
10. BoomWH, Canaday D H, Fulton S A, Gehring A J, Rojas R E, Torres M.Human immunity to M.tuberculosis: T-cell subsets and antigen processing Tuberculosis 2003; 83: 98-106.
11. Raby E, Moyo M, Devendra A, et al The effects of HIV on the sensitivity of a whole blood IFN-gamma release assay in Zambian adults with active tuberculosis PLOS ONE 2008; 3: e2489.
12. Turner J, DockrellHM Stimulation of human peripheral blood mononuclear cells with live Mycobacterium bovis BCG activates cytolytic CD8+ T cells in vitro Immunology 1996; 87: 339-342.
13. Brookes R H, Pathan A A, McShane H, Hensmann M, Price D A, Hill AV CD8+T cell-mediated suppression of intracellular Mycobacterium tuberculosis growth in activated human macrophages Eur J Immunol 2003; 33: 3293-3302.
14. Lewinsohn D A, Winata E, Swarbrick G M, et al Immunodominant tuberculosis CD8 antigens preferentially restricted by HLA-B PLOS pathog 2007; 3: 1240-1249.
15. Lalvani A, Brookes R, Wilkinson R J, et al Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis Proc Natl Acad Sci USA 1998; 95: 270-275.
16. Qiagen QuantiFERONw-TB Gold Plus (QFT-Plus) ELISA package insert Hilden, Germany: Qiagen, 2015 http://www quantiferon.com/irm/content/PI/QFT/PLUS/2PK-Elisa/UK.pdf Accessed March 2017.
17. Ministry of Health Zambia National Guidelines for HIV counselling and testing 2006 Lusaka, Zambia: MoH, 2006 http://hivstar.lshtm.ac.uk/files/2016/05/Zambia-National-Guidelines-for-HIV-Counsellig-And-Testing2006.pdf Accessed March 2017.
18. World Health Organization Global database on body mass index 2015 Geneva, Switzerland: WHO, 2015 http://apps who.int/bmi/index.jsp?introPage=intro-3.html.
19. Bossuyt P M, Reitsma J B, Bruns D E, et al STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies BMJ 2015; 351: h5527.
20. Barcellini L, Borroni E, Brown J, et al First independent evaluation of QuantiFERON-TB Plus performance Eur Respir J 2016; 47: 1587-1590.
21. Yi L, Sasaki Y, Nagai H, et al Evaluation of QuantiFERON-TB Gold Plus for Detection of Mycobacterium tuberculosis infection in Japan Sci Rep 2016; 6: 30617.
22. Hoffmann H, Avsar K, Gores R, Mavi S C, Hofmann-Thiel S.Equal sensitivity of the new generation QuantiFERON-TB Gold plus in direct comparison with the previous test version QuantiFERON-TB Gold IT Clin Microbiol Infect 2016; 22: 701-703.
23. World Health Organization Use of tuberculosis interferon gamma release assays (IGRAs) in low-And middle-income countries: policy statement WHO/HTM/TB/2011.18 Geneva, Switzerland: WHO, 2011 http://www.who.int/tb/features-Archive/policy-statement-igra-oct2011.pdf Accessed March 2017.
24. Perkins M D.New diagnostic tools for tuberculosis Int J Tuberc Lung Dis 2000; 4 (Suppl 2): S182-188.
25. Boehme CC, Nicol MP, Nabeta P, et al Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study Lancet 2011; 377: 1495-1505.
26. Steingart K R, Sohn H, Schiller I, et al Xpertw MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults Cochrane Database Syst Rev 2013; 1: CD009593.
27. Boussiotis V A, Tsai E Y, Yunis E J, et al IL-10-producing T cells suppress immune responses in anergic tuberculosis patients J Clin Invest 2000; 105: 1317-1325.